← All stocks

Faeth Therapeutics, Inc.

FTH Net buying
CIK 0001829802 #2705 in the set updated 17 Sep 2026
Bought (120 mo)
$10.80M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.40M
$0.00 on a plan · $82.48K straight out of an exercise
Sold at will
$8.32M
44 of 51 sales
Net
+$2.40M
+$2.48M against sales at will

By person

20 insiders · 229 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Apeiron Investment Group Ltd. entity
10% owner
$3.54K (2)
$5.44M (2)
−$5.43M
0
$0.00
−100.0%
Cambrian BioPharma Inc entity
10% owner
$4.01M (61)
$787.81K (10)
+$3.22M
130,142
$3.15M
Peyer James
10% owner
$4.01M (61)
$787.81K (10)
+$3.22M
5,097,528
$123.46M
+34.9%
STEPHENSON BRIAN C
Chief Financial Officer
$1.13M (22)
+$1.13M
46,688
$1.13M
Pierce Robert Hamilton
Chief R&D Officer
$685.96K (4)
−$685.96K
21,000
$508.62K
−78.1%
MILLENNIUM MANAGEMENT LLC entity
10% owner
$1.34M (26)
$704.45K (25)
+$637.27K
133,986
$3.25M
+21.7%
RICKS THOMAS G
Director
$249.60K (2)
+$249.60K
652,470
$15.80M
+116.2%
Parikh Anand Kiran
President and CEO
$55.45K (1)
+$55.45K
817,699
$19.80M
Celebi John
PRESIDENT AND CEO
$425.00 (1)
+$425.00
105,862
$2.56M
+936.8%
H&S INVESTMENTS I LP entity
10% owner
4,425,998
$107.20M
+6,798%
Colgan Erin
CHIEF FINANCIAL OFFICER
67,462
$1.63M
+596.5%
van der Horst Edward
CHIEF SCIENTIFIC OFFICER
59,794
$1.45M
+80.2%
Hahn Stephen M.
Director
44,763
$1.08M
Gallagher Patrick Stephen
Chief Business Officer
43,515
$1.05M
+363.7%
Holmen Bob
Director
25,598
$619.98K
+53.6%
RINGO WILLIAM R
Director
23,399
$566.72K
Humer Kristian
Director
8,932
$216.33K
English Jessie
Director
8,932
$216.33K
Vojta Deneen
Director
8,932
$216.33K
Broder Samuel
Director
8,932
$216.33K

No percentages here. This company's share count has moved by a factor of 20.5 over the window, from 1,261,290 to 25,840,425 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Peyer James
1 Jun 2026
10% owner
Sell
476
$21.14
$10.06K
Peyer James
1 Jun 2026
10% owner
Sell
24,524
$20.00
$490.48K
Cambrian BioPharma Inc
1 Jun 2026
10% owner
Sell
476
$21.14
$10.06K
Cambrian BioPharma Inc
1 Jun 2026
10% owner
Sell
24,524
$20.00
$490.48K
MILLENNIUM MANAGEMENT LLC
7 Apr 2026
10% owner
Sell indirect
1,108
$33.38
$36.99K
MILLENNIUM MANAGEMENT LLC
7 Apr 2026
10% owner
Sell indirect
300
$32.25
$9.67K
MILLENNIUM MANAGEMENT LLC
7 Apr 2026
10% owner
Sell indirect
4,423
$31.38
$138.81K
MILLENNIUM MANAGEMENT LLC
7 Apr 2026
10% owner
Sell indirect
205
$29.71
$6.09K
MILLENNIUM MANAGEMENT LLC
7 Apr 2026
10% owner
Sell indirect
2,115
$28.94
$61.21K
MILLENNIUM MANAGEMENT LLC
6 Apr 2026
10% owner
Sell indirect
45
$31.96
$1.44K
MILLENNIUM MANAGEMENT LLC
6 Apr 2026
10% owner
Sell indirect
1,214
$31.02
$37.66K
MILLENNIUM MANAGEMENT LLC
2 Apr 2026
10% owner
Sell indirect
1,134
$34.80
$39.46K
MILLENNIUM MANAGEMENT LLC
2 Apr 2026
10% owner
Sell indirect
374
$33.35
$12.47K
MILLENNIUM MANAGEMENT LLC
2 Apr 2026
10% owner
Sell indirect
1,794
$32.60
$58.49K
MILLENNIUM MANAGEMENT LLC
2 Apr 2026
10% owner
Sell indirect
1,265
$31.75
$40.17K
MILLENNIUM MANAGEMENT LLC
2 Apr 2026
10% owner
Sell indirect
3,099
$30.86
$95.65K
MILLENNIUM MANAGEMENT LLC
1 Apr 2026
10% owner
Sell indirect
46
$34.75
$1.60K
MILLENNIUM MANAGEMENT LLC
1 Apr 2026
10% owner
Sell indirect
1,104
$31.52
$34.80K
MILLENNIUM MANAGEMENT LLC
31 Mar 2026
10% owner
Sell indirect
87
$31.52
$2.74K
MILLENNIUM MANAGEMENT LLC
31 Mar 2026
10% owner
Sell indirect
5
$28.41
$142.03
MILLENNIUM MANAGEMENT LLC
31 Mar 2026
10% owner
Sell indirect
57
$27.11
$1.55K
MILLENNIUM MANAGEMENT LLC
31 Mar 2026
10% owner
Sell indirect
1,251
$25.17
$31.48K
MILLENNIUM MANAGEMENT LLC
31 Mar 2026
10% owner
Sell indirect
191
$24.28
$4.64K
MILLENNIUM MANAGEMENT LLC
30 Mar 2026
10% owner
Sell indirect
370
$27.68
$10.24K
MILLENNIUM MANAGEMENT LLC
30 Mar 2026
10% owner
Sell indirect
518
$25.85
$13.39K
MILLENNIUM MANAGEMENT LLC
27 Mar 2026
10% owner
Sell indirect
36
$27.37
$985.28
MILLENNIUM MANAGEMENT LLC
27 Mar 2026
10% owner
Sell indirect
469
$26.77
$12.55K
MILLENNIUM MANAGEMENT LLC
26 Mar 2026
10% owner
Sell indirect
1,274
$28.69
$36.55K
MILLENNIUM MANAGEMENT LLC
26 Mar 2026
10% owner
Sell indirect
583
$26.88
$15.67K
Peyer James
8 Dec 2025
10% owner
Sell indirect
3,105
$8.59
$26.67K
Peyer James
5 Dec 2025
10% owner
Sell indirect
42
$13.16
$552.72
Peyer James
5 Dec 2025
10% owner
Sell indirect
1,745
$12.29
$21.45K
Peyer James
5 Dec 2025
10% owner
Sell indirect
14,508
$11.40
$165.39K
Cambrian BioPharma Inc
5 Dec 2025
10% owner
Sell
42
$13.16
$552.72
Cambrian BioPharma Inc
5 Dec 2025
10% owner
Sell
1,745
$12.29
$21.45K
Cambrian BioPharma Inc
5 Dec 2025
10% owner
Sell
14,508
$11.40
$165.39K
Peyer James
4 Dec 2025
10% owner
Sell indirect
5,000
$9.06
$45.30K
Cambrian BioPharma Inc
4 Dec 2025
10% owner
Sell
5,000
$9.06
$45.30K
Apeiron Investment Group Ltd.
1 Jun 2023
10% owner
Sell indirect
955,738
$1.58
$1.51M
Apeiron Investment Group Ltd.
1 Jun 2023
10% owner
Sell indirect
2,485,923
$1.58
$3.93M
Pierce Robert Hamilton
11 Aug 2021
Chief Scientific Officer
Sell indirect
16,030
$7.34
$117.72K
Pierce Robert Hamilton
10 Aug 2021
Chief Scientific Officer
Sell indirect
66,350
$7.13
$473.00K
Pierce Robert Hamilton
9 Aug 2021
Chief Scientific Officer
Sell indirect
6,982
$7.06
$49.30K
Pierce Robert Hamilton
6 Aug 2021
Chief Scientific Officer
Sell indirect
6,460
$7.11
$45.95K

What was left out

Form 4 filings counted 197
Amendments (4/A) skipped 13
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 13,983,920
Sales filed before the plan box existed 4
History held since 5 Feb 2021